CLINICAL_TRIALS
trial_result
· 2013-07-02
Clinical Trial Update: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) [Phase 3]
Summary
Phase 3, 6-week monotherapy trial of lurasidone for Bipolar I depression, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2013-07-02